Go Pro
→ Your book attached (From Profits Run) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AtriCure, Inc. stock logo
ATRC
AtriCure
$55.14
+2.9%		$49.44
$25.36
▼
$61.70
$2.80B1.241.57 million shs1.62 million shs
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
$8.92
+4.5%		$8.39
$1.90
▼
$10.05
$2.38B2.045.28 million shs4.48 million shs
SiBone stock logo
SIBN
SiBone
$18.08
-1.8%		$18.68
$11.48
▼
$21.89
$801.83M0.66543,272 shs547,320 shs
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$79.79
+1.5%		$85.61
$60.10
▼
$156.00
$2.76B1.94685,666 shs1.22 million shs
The 10 Best High-Yield Dividend Stocks for 2026 Cover
The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AtriCure, Inc. stock logo
ATRC
AtriCure
0.00%-5.55%+5.11%+73.45%+61.09%
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
0.00%-5.46%+22.82%+15.97%+368.08%
SiBone stock logo
SIBN
SiBone
0.00%-2.74%-3.00%+5.67%+26.70%
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
0.00%-6.45%-8.27%+15.87%-30.55%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AtriCure, Inc. stock logo
ATRC
AtriCure
$55.14
+2.9%		$49.44
$25.36
▼
$61.70
$2.80B1.241.57 million shs1.62 million shs
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
$8.92
+4.5%		$8.39
$1.90
▼
$10.05
$2.38B2.045.28 million shs4.48 million shs
SiBone stock logo
SIBN
SiBone
$18.08
-1.8%		$18.68
$11.48
▼
$21.89
$801.83M0.66543,272 shs547,320 shs
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$79.79
+1.5%		$85.61
$60.10
▼
$156.00
$2.76B1.94685,666 shs1.22 million shs
The 10 Best High-Yield Dividend Stocks for 2026 Cover
The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AtriCure, Inc. stock logo
ATRC
AtriCure
0.00%-5.55%+5.11%+73.45%+61.09%
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
0.00%-5.46%+22.82%+15.97%+368.08%
SiBone stock logo
SIBN
SiBone
0.00%-2.74%-3.00%+5.67%+26.70%
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
0.00%-6.45%-8.27%+15.87%-30.55%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AtriCure, Inc. stock logo
ATRC
AtriCure
2.58
Moderate Buy$53.30-3.34% Downside
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
2.71
Moderate Buy$8.54-4.21% Downside
SiBone stock logo
SIBN
SiBone
2.71
Moderate Buy$24.1733.67% Upside
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
2.33
Hold$121.1051.77% Upside

Current Analyst Ratings Breakdown

Latest SIBN, ATRC, TMDX, and BFLY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/2/2026
AtriCure, Inc. stock logo
ATRC
AtriCure
Freedom Capital logo
Freedom Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
9/29/2026
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
Evercore Inc logo
Evercore
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageOutperform$15.00
9/29/2026
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
Evercore Inc logo
Evercore
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageOutperform$15.00
9/29/2026
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
Evercore Inc logo
Evercore
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong-Buy
9/22/2026
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
Needham & Company LLC logo
Needham & Company LLC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$10.00
9/22/2026
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
Needham & Company LLC logo
Needham & Company LLC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$10.00
9/17/2026
AtriCure, Inc. stock logo
ATRC
AtriCure
Stifel Nicolaus logo
Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$65.00
9/11/2026
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
Needham & Company LLC logo
Needham & Company LLC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy
9/11/2026
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
TD Cowen logo
TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$10.00
9/8/2026
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
TD Cowen logo
TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$120.00
9/2/2026
AtriCure, Inc. stock logo
ATRC
AtriCure
Needham & Company LLC logo
Needham & Company LLC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$45.00 ➝ $64.00
(Data available from 10/4/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AtriCure, Inc. stock logo
ATRC
AtriCure
$534.53M5.25$0.31 per share176.17$9.89 per share5.58
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
$97.61M24.33N/AN/A$0.77 per share11.58
SiBone stock logo
SIBN
SiBone
$200.93M3.99N/AN/A$4.09 per share4.42
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$605.49M4.55$3.93 per share20.32$13.79 per share5.79
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AtriCure, Inc. stock logo
ATRC
AtriCure
-$11.45M$0.21262.58122.53N/A1.85%2.34%1.77%11/4/2026 (Estimated)
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
-$77.06M-$0.29N/AN/AN/A-66.74%-33.99%-22.96%10/30/2026 (Estimated)
SiBone stock logo
SIBN
SiBone
-$18.90M-$0.34N/AN/AN/A-6.85%-8.23%-6.07%11/9/2026 (Estimated)
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$190.29M$3.8920.5135.311.1022.69%15.88%5.95%11/4/2026 (Estimated)

Latest SIBN, ATRC, TMDX, and BFLY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
10/30/2026Q3 2026
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
-$0.0360N/AN/AN/A$28.23 millionN/A
8/4/2026Q2 2026
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$0.4955$0.44-$0.0555$0.41$184.00 million$189.95 million
8/3/2026Q2 2026
SiBone stock logo
SIBN
SiBone
-$0.1495-$0.09+$0.0595-$0.09$55.34 million$56.01 million
7/30/2026Q2 2026
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
-$0.0350-$0.01+$0.0250-$0.05$29.16 million$32.61 million
7/23/2026Q2 2026
AtriCure, Inc. stock logo
ATRC
AtriCure
-$0.0017$0.18+$0.1817$0.18$151.80 million$153.60 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
AtriCure, Inc. stock logo
ATRC
AtriCure
N/AN/AN/AN/AN/A
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
N/AN/AN/AN/AN/A
SiBone stock logo
SIBN
SiBone
N/AN/AN/AN/AN/A
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AtriCure, Inc. stock logo
ATRC
AtriCure
0.14
4.22
3.19
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
N/A
4.06
3.06
SiBone stock logo
SIBN
SiBone
0.20
9.15
7.55
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
1.62
6.62
6.07

Institutional Ownership

CompanyInstitutional Ownership
AtriCure, Inc. stock logo
ATRC
AtriCure
99.11%
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
37.85%
SiBone stock logo
SIBN
SiBone
98.11%
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
99.67%

Insider Ownership

CompanyInsider Ownership
AtriCure, Inc. stock logo
ATRC
AtriCure
4.00%
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
21.99%
SiBone stock logo
SIBN
SiBone
4.00%
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
6.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
AtriCure, Inc. stock logo
ATRC
AtriCure
1,35050.87 million48.83 millionOptionable
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
220266.29 million207.73 millionOptionable
SiBone stock logo
SIBN
SiBone
37644.35 million42.58 millionOptionable
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
89834.56 million32.18 millionOptionable

Recent News About These Companies

Analysts Have Conflicting Sentiments on These Healthcare Companies: TransMedics Group (TMDX), Regeneron (REGN) and Tarsus Pharmaceuticals (TARS)
October 3 at 12:44 PM  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/TMDX/pressreleases/4943383/analysts-have-conflicting-sentiments-on-these-healthcare-companies-transmedics-group-tmdx-regeneron-regn-and-tarsus-pharmaceuticals-tars/
Analysts Have Conflicting Sentiments on These Healthcare Companies: TransMedics Group (TMDX), Regeneron (REGN) and Tarsus Pharmaceuticals (TARS)
October 3 at 12:44 PM  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/TMDX/pressreleases/4943383/analysts-have-conflicting-sentiments-on-these-healthcare-companies-transmedics-group-tmdx-regeneron-regn-and-tarsus-pharmaceuticals-tars/
TransMedics Group (TMDX) Could Be 19% Undervalued If Its Growth Narrative Holds
October 2 at 6:27 AM  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/transmedics-group-tmdx-could-19-060700455.html
TransMedics Director David Weill Purchases $109,000 of Stock -- Should Investors Buy Too?
September 29, 2026  |  fool.comhttps://www.fool.com/coverage/filings/2026/09/29/transmedics-director-david-weill-purchases-usd109-000-of-stock-should-investors-buy-too/
TransMedics (TMDX)
September 28, 2026  |  es.investing.comhttps://es.investing.com/equities/transmedics-group-inc
Head-To-Head Contrast: TransMedics Group (NASDAQ:TMDX) & Nephros (NASDAQ:NEPH)
September 27, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31055008
Stock Traders Purchase High Volume of TransMedics Group Put Options (NASDAQ:TMDX)
September 27, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31053781
TransMedics Offers An Attractive Entry Point, With Upside Potential Outweighing Risks
September 26, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4949948-transmedics-offers-an-attractive-entry-point-with-upside-potential-outweighing-risks
Did TransMedics Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
September 26, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/did-transmedics-group-inc-insiders-breach-their-fiduciary-duties-to-shareholders-302890731.html
Investors Purchase Large Volume of TransMedics Group Put Options (NASDAQ:TMDX)
September 25, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/options-investors-purchase-large-volume-of-transmedics-group-put-options-nasdaq-tmdx-2026-09-25/
Analysts Offer Insights on Healthcare Companies: DBV Technologies SA – American (DBVT) and TransMedics Group (TMDX)
September 23, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/TMDX/pressreleases/4750087/analysts-offer-insights-on-healthcare-companies-dbv-technologies-sa-american-dbvt-and-transmedics-group-tmdx/
【TMDX】TransMedics Group
September 19, 2026  |  note.comN
TransMedics: Waiting On 2027 Catalysts (Rating Upgrade)
September 18, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4947750-transmedics-waiting-on-2027-catalysts
TransMedics Group, Inc. (TMDX) Presents at 2026 Global Healthcare Conference - Slideshow
September 15, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4946659-transmedics-group-inc-tmdx-presents-at-2026-global-healthcare-conference-slideshow
TransMedics Group (NASDAQ:TMDX) Trading Up 4.5% on Insider Buying Activity
September 15, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-transmedics-group-nasdaq-tmdx-trading-up-45-on-insider-buying-activity-2026-09-15/
2 Stocks Down 28% and 34% to Buy and Hold
September 15, 2026  |  fool.comhttps://www.fool.com/investing/2026/09/15/2-stocks-down-28-and-34-that-to-buy-and-hold/
Insider Buying: TransMedics Group (NASDAQ:TMDX) Director Purchases $109,057.68 in Stock
September 15, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-tmdx-insider-buying-and-selling-2026-09-15/
TransMedics Group, Inc. (TMDX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
September 14, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4946220-transmedics-group-inc-tmdx-presents-at-morgan-stanley-24th-annual-global-healthcare
Insider Buying: TransMedics Group (NASDAQ:TMDX) Director Buys 1,336 Shares of Stock
September 14, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-insider-buying-transmedics-group-nasdaq-tmdx-director-buys-1336-shares-of-stock-2026-09-14/
TransMedics Group Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of TransMedics Group, Inc. - TMDX
September 14, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260914420394/en/transmedics-group-investigation-initiated-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-transmedics-group-inc.---tmdx/
Canaccord Genuity Keeps Their Buy Rating on TransMedics Group (TMDX)
September 12, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/4572061/canaccord-genuity-keeps-their-buy-rating-on-transmedics-group-tmdx/

New MarketBeat Followers Over Time

Media Sentiment Over Time

AtriCure stock logo

AtriCure NASDAQ:ATRC

$55.14 +1.55 (+2.89%)
Closing price 10/2/2026 04:00 PM Eastern
Extended Trading
$55.11 -0.03 (-0.05%)
As of 10/2/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

AtriCure, Inc. develops, manufactures, and sells devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, Europe, the Asia-Pacific, and internationally. The company offers Isolator Synergy Clamps, single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation, and ablate cardiac tissue with the same device; and the Coolrail device, which enables users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; cryoSPHERE probe, which provides temporary pain relief by applying cryothermic energy to targeted intercoastal peripheral nerves in the ribcage; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure. In addition, the company sells Lumitip dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.

Butterfly Network stock logo

Butterfly Network NYSE:BFLY

$8.92 +0.39 (+4.54%)
Closing price 10/2/2026 03:59 PM Eastern
Extended Trading
$8.94 +0.02 (+0.26%)
As of 10/2/2026 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging in a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; and Butterfly iQ+ Vet, a handheld ultrasound system designed for veterinarians. The company also provides Butterfly system, which includes probes, and related accessories and software subscriptions to healthcare systems, physicians, and healthcare providers through a direct sales force, distributors, and eCommerce channel. In addition, it offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials, and formal education programs through its Butterfly Academy software, as well as professional services for large scale deployments; and ScanLab, an education-only app provides written walkthroughs and reference imagery to guide real-time educational scanning, enhancing the learning process. Butterfly Network, Inc. was founded in 2011 and is headquartered in Burlington, Massachusetts.

SiBone stock logo

SiBone NASDAQ:SIBN

$18.08 -0.33 (-1.79%)
Closing price 10/2/2026 04:00 PM Eastern
Extended Trading
$18.09 +0.01 (+0.06%)
As of 10/2/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

TransMedics Group stock logo

TransMedics Group NASDAQ:TMDX

$79.79 +1.15 (+1.46%)
Closing price 10/2/2026 04:00 PM Eastern
Extended Trading
$79.10 -0.69 (-0.86%)
As of 10/2/2026 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas